These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 10201674)
1. Pharmacokinetic modeling of M6G formation after oral administration of morphine in healthy volunteers. Lötsch J; Weiss M; Ahne G; Kobal G; Geisslinger G Anesthesiology; 1999 Apr; 90(4):1026-38. PubMed ID: 10201674 [TBL] [Abstract][Full Text] [Related]
2. The bioavailability and pharmacokinetics of subcutaneous, nebulized and oral morphine-6-glucuronide. Penson RT; Joel SP; Roberts M; Gloyne A; Beckwith S; Slevin ML Br J Clin Pharmacol; 2002 Apr; 53(4):347-54. PubMed ID: 11966664 [TBL] [Abstract][Full Text] [Related]
4. Morphine-6-glucuronide is responsible for the analgesic effect after morphine administration: a quantitative review of morphine, morphine-6-glucuronide, and morphine-3-glucuronide. Klimas R; Mikus G Br J Anaesth; 2014 Dec; 113(6):935-44. PubMed ID: 24985077 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic modeling to predict morphine and morphine-6-glucuronide plasma concentrations in healthy young volunteers. Lötsch J; Skarke C; Schmidt H; Liefhold J; Geisslinger G Clin Pharmacol Ther; 2002 Aug; 72(2):151-62. PubMed ID: 12189362 [TBL] [Abstract][Full Text] [Related]
6. Morphine pharmacokinetics and metabolism in humans. Enterohepatic cycling and relative contribution of metabolites to active opioid concentrations. Hasselström J; Säwe J Clin Pharmacokinet; 1993 Apr; 24(4):344-54. PubMed ID: 8491060 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic-pharmacodynamic modeling of morphine-6-glucuronide-induced analgesia in healthy volunteers: absence of sex differences. Romberg R; Olofsen E; Sarton E; den Hartigh J; Taschner PE; Dahan A Anesthesiology; 2004 Jan; 100(1):120-33. PubMed ID: 14695733 [TBL] [Abstract][Full Text] [Related]
8. The influence of the route of administration: a comparative study at steady state of oral sustained release morphine and morphine sulfate suppositories. Du X; Skopp G; Aderjan R Ther Drug Monit; 1999 Apr; 21(2):208-14. PubMed ID: 10217341 [TBL] [Abstract][Full Text] [Related]
9. The pharmacokinetics of morphine and morphine glucuronide metabolites after subcutaneous bolus injection and subcutaneous infusion of morphine. Stuart-Harris R; Joel SP; McDonald P; Currow D; Slevin ML Br J Clin Pharmacol; 2000 Mar; 49(3):207-14. PubMed ID: 10718775 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of morphine and its glucuronides following intravenous administration of morphine in patients undergoing continuous ambulatory peritoneal dialysis. Pauli-Magnus C; Hofmann U; Mikus G; Kuhlmann U; Mettang T Nephrol Dial Transplant; 1999 Apr; 14(4):903-9. PubMed ID: 10328468 [TBL] [Abstract][Full Text] [Related]
11. The transfer half-life of morphine-6-glucuronide from plasma to effect site assessed by pupil size measurement in healthy volunteers. Lötsch J; Skarke C; Schmidt H; Grösch S; Geisslinger G Anesthesiology; 2001 Dec; 95(6):1329-38. PubMed ID: 11748388 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of morphine and its glucuronidated metabolites in burn injuries. Perreault S; Choinière M; du Souich PB; Bellavance F; Beauregard G Ann Pharmacother; 2001 Dec; 35(12):1588-92. PubMed ID: 11793627 [TBL] [Abstract][Full Text] [Related]
13. The effect of old age on the disposition and antinociceptive response of morphine and morphine-6 beta-glucuronide in the rat. Van Crugten JT; Somogyi AA; Nation RL; Reynolds G Pain; 1997 Jun; 71(2):199-205. PubMed ID: 9211481 [TBL] [Abstract][Full Text] [Related]
14. Contribution of morphine-6-glucuronide to antinociception following intravenous administration of morphine to healthy volunteers. Murthy BR; Pollack GM; Brouwer KL J Clin Pharmacol; 2002 May; 42(5):569-76. PubMed ID: 12017351 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of Morphine and Morphine-6-Glucuronide During Postoperative Pain Therapy in Cardiac Surgery Patients. Ihmsen H; Schüttler J; Jeleazcov C Eur J Drug Metab Pharmacokinet; 2021 Mar; 46(2):249-263. PubMed ID: 33547559 [TBL] [Abstract][Full Text] [Related]
17. A Compartmental Analysis for Morphine and Its Metabolites in Young Children After a Single Oral Dose. Velez de Mendizabal N; Jimenez-Mendez R; Cooke E; Montgomery CJ; Dawes J; Rieder MJ; Aleksa K; Koren G; Jacobo-Cabral CO; Gonzalez-Ramirez R; Castañeda-Hernandez G; Carleton BC Clin Pharmacokinet; 2015 Oct; 54(10):1083-90. PubMed ID: 25773480 [TBL] [Abstract][Full Text] [Related]
18. A Prospective Population Pharmacokinetic Study on Morphine Metabolism in Cancer Patients. Oosten AW; Abrantes JA; Jönsson S; Matic M; van Schaik RHN; de Bruijn P; van der Rijt CCD; Mathijssen RHJ Clin Pharmacokinet; 2017 Jul; 56(7):733-746. PubMed ID: 27815868 [TBL] [Abstract][Full Text] [Related]
19. PBPK-PD model for predicting morphine pharmacokinetics, CNS effects and naloxone antagonism in humans. Mu RJ; Liu TL; Liu XD; Liu L Acta Pharmacol Sin; 2024 Aug; 45(8):1752-1764. PubMed ID: 38570601 [TBL] [Abstract][Full Text] [Related]
20. Influence of Morbid Obesity on the Pharmacokinetics of Morphine, Morphine-3-Glucuronide, and Morphine-6-Glucuronide. de Hoogd S; Välitalo PAJ; Dahan A; van Kralingen S; Coughtrie MMW; van Dongen EPA; van Ramshorst B; Knibbe CAJ Clin Pharmacokinet; 2017 Dec; 56(12):1577-1587. PubMed ID: 28510797 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]